Skip to main content
Download PDF

1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca2+-ATPase from sarcoplasmic reticulum

BMC Biochemistry volume 17, Article number: 5 (2016) Cite this article

Abstract

Background

1,2-Dichlorobenzene (1,2-DCB) is a benzene-derived molecule with two Cl atoms that is commonly utilized in the synthesis of pesticides. 1,2-DCB can be absorbed by living creatures and its effects on naturally-occurring enzymatic systems, including the effects on Ca2+-ATPases, have been poorly studied. Therefore, we aimed to study the effect of 1,2-DCB on the Ca2+-ATPase from sarcoplasmic reticulum (SERCA), a critical regulator of intracellular Ca2+ concentration.

Results

Concentrations of 0.05–0.2 mM of 1,2-DCB were able to stimulate the hydrolytic activity of SERCA in a medium-containing Ca2+-ionophore. At higher concentrations (0.25–0.75 mM), 1,2-DCB inhibited the ATP hydrolysis to ~80 %. Moreover, ATP hydrolysis and Ca2+ uptake in a medium supported by K-oxalate showed that starting at 0.05 mM,1,2-DCB was able to uncouple the ratio of hydrolysis/Ca2+ transported. The effect of this compound on the integrity of the SR membrane loaded with Ca2+ remained unaffected. Finally, the analysis of phosphorylation of SERCA by [γ-32P]ATP, starting under different conditions at 0° or 25 °C showed a reduction in the phosphoenzyme levels by 1,2-DCB, mostly at 0 °C.

Conclusions

The temperature-dependent decreased levels of phosphoenzyme by 1,2-DCB could be due to the acceleration of the dephosphorylation mechanism – E2P · Ca2 state to E2 and Pi, which explains the uncoupling of the ATP hydrolysis from the Ca2+ transport.

Background

1,2-Dichlorobenzene (1,2-DCB) is a chlorinated benzene molecule used as precursor in the synthesis of pesticides. 1,2-DCB can be absorbed and accumulated by humans and wildlife, and it has been detected in different biological fluids. Moreover, 1,2-DCB has been linked to severe human health problems such as liver damage and anemia [1–6]. Oral administration of a radioactively-labeled 1,2-DCB to rats revealed that it can be distributed among all tissues, including skeletal muscle. In addition, it has been shown that DCB molecules can induce a rise in intracellular Ca2+ in human neuronal SH-SY5Y cells [7, 8]. Given this evidence, we hypothesized that 1,2-DCB can affect the functionality of skeletal muscle proteins, particularly the Ca2+-ATPase from sarcoplasmic reticulum (SERCA), a predominant protein of skeletal muscle, a hypothesis that has not previously been explored. SERCA is a large (110-kDa) sarcoplasmic reticulum protein with 10 transmembrane regions, and it plays the essential role of reducing the intracellular Ca2+ concentration by consuming ATP as a source of energy [9–12]. Each molecule of SERCA protein utilizes the energy of one ATP molecule to pump 2Ca2+ across the sarcoplasmic membrane, thus maintaining low cytoplasmic Ca2+ concentrations and high intravesicular Ca2+ concentrations [13, 14]. The catalytic cycle of SERCA involves two main conformational states, E1 with high-Ca2+ and E2 with low-Ca2+ affinities [15–17]. In addition, the three-dimensional structures of the two conformational stages of SERCA and phosphorylated intermediate (EP) have been successfully determined [18–22]. Furthermore, the coupling ratio of both transported Ca2+ and hydrolyzed ATP occurs through a sequence of phosphorylated and non-phosphorylated enzymatic intermediates, with or without Ca2+ bound to the enzyme, and it has been shown that EP accumulation can serve as an indicator of enzyme turnover, which can be affected by a variety of factors such as temperature, nature of the substrate, Ca2+ concentration and presence of organic solvents [23].

Given the critical role of SERCA in maintaining appropriate cytosolic Ca2+ levels, chemical agents that affect its functionality can have harmful effects to the overall cellular function. In this regard, a multitude of molecules have been described to act as inhibitors of SERCA [24]. Naturally-occurring compounds such as cyclopiazonic acid (a fungal toxin), and thapsigargin (a sesquiterpene lactone) are two of the most widely used inhibitors of SERCA [25–27]. Inorganic compounds such as vanadate, tungstate and molybdate have also been reported to inhibit SERCA activity [28–31]. Other natural compounds such as ellagic acid and gingerol, which have been described to stimulate SERCA activity, have been shown to be promising therapeutic targets for cardiovascular dysfunction [32, 33]. In addition, several molecules, including thapsigargin derivatives and flavonoids are being developed as potential cancer treatments based on their SERCA-mediated anti-proliferative and pro-apoptotic effects [34, 35]. Furthermore, a broad variety of organic solvents and hydrophobic compounds bearing nucleophilic groups have been extensively reported as inhibitors of SERCA activity [36–41]. The inhibitory effect of these compounds was related to their hydrophobicity, and notably, they were also able to stimulate SERCA activity at certain concentrations. In this study, we provide evidence, for the first time, that 1,2-DCB affects Ca2+ homeostasis by affecting SERCA, a fundamental Ca2+ modulator. We report here the effect of 1,2-DCB on several key features of SERCA, including ATP hydrolytic activity, the ratio of hydrolysis of ATP/Ca2+ transported, and the phosphorylation stage (EP) during the catalytic cycle of this enzyme.

Methods

Chemicals and reagents

[γ-32P]ATP and 45CaCl2 were purchased from Perkin-Elmer, USA. [3H]Glucose and 45CaCl2 were products of DuPont NEN. The Ca2+ ionophore A23187 (calcimycin), EGTA (ethylene glycol-bis (β-aminoethyl ether)-N,N,N’,N’-tetra acetic acid), Mops (4-morpholinepropanesulfonic acid), liquid scintillation cocktail (Sigma-Fluor S-4023), ATP disodium salt, LaCl3, K-oxalate, benzene, 1,2-DCB was obtained from Sigma, Co. (St. Louis, MO). CaCl2 and other chemicals ware purchased from J.T. Baker (México). The Ca2+ ionophore A23187 was dissolved in ethanol. Benzene and 1,2-DCB were dissolved in methanol. Ethanol and methanol never reached a concentration higher than 1 % (v/v) in the reaction media after the addition of 1,2-DCB or A23187.

Preparation of sarcoplasmic vesicles

SR (sarcoplasmic reticulum) membranes rich in Ca2+-ATPase (SERCA) were prepared from the low density SR of skeletal fast-twitch muscle of adult New Zealand rabbit hind limbs, and preserved in a buffer containing 10 mM Mops, pH 7.0 and 30 % sucrose and stored at −80 °C as described by Eletr and Inesi [42]. The sarcoplasmic membrane concentration refers to milligrams (mg) of total protein per milliliters (ml) and was measured by the colorimetric procedure described by Lowry et al. [43]. We used bovine serum albumin as standard protein.

Free Ca2+ concentration in the reaction media

Free Ca2+ concentration was adjusted by adding the appropriate volume of CaCl2 and EGTA to the enzymatic reaction media [44]. Free Ca2+ concentration was calculated by the computer program Calcium which is based on the absolute constant stability for the Ca2+-EGTA complex, the EGTA protonation equilibrium, Ca2+ ligands and media pH [45, 46].

Ca2+-ATPase (SERCA) hydrolytic activity supported by A23187 or K-oxalate

Initial rates of ATP hydrolysis by SR vesicles were measured at 25 °C for 5 min (min) by following the liberation of inorganic phosphate (Pi). A typical assay medium was buffered at pH 7.0, and contained 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.967 mM CaCl2 (10 μM free Ca2+),0.01 mg/ml SR vesicles, 1.5 μM A23187 (to generate leaky vesicles to measure in min) or 5 mM K-oxalate (no leaks and to measure in min). A typical reaction was started after the addition of 1 mM of ATP. Any change in the concentration of SR protein added to the reaction medium is detailed in the figure captions. The compound 1,2-DCB was added at the indicated concentrations (0.05–1 mM). The appearance of Pi from the hydrolysis of ATP mediated by SERCA was evaluated with a molybdovanadate reagent previously described by Lin and Morales [47]. Experimental details are indicated in the corresponding figure legends.

Ca2+ uptake supported by K-oxalate

SERCA is a Ca2+ pump that depends on Mg2+ and the presence of ATP to transport Ca2+ across of the SR membrane. For this reason, we studied the Ca2+ transported by SERCA in the presence of 1,2-DCB. Ca2+ transported by SERCA was measured at 25 °C using 45CaCl2 as a radioactive tracer followed by sample filtration according with the methods described by Martonosi and Feretos [48]. The experiment was conducted in a reaction mixture containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 5 mM K-oxalate instead of ionophore A23187 (to keep vesicles intact), 0.967 mM CaCl2 (10 μM free Ca2+) with 1000 cpm 45CaCl2 per nmol of Ca2+, and different concentrations of 1,2-DCB. The reaction contained 0.01 mg/ml of protein and was started after adding 1 mM of ATP. Ca2+ uptake mediated by SERCA was stopped by filtering the vesicles in 0.45 μm HA type nitrocellulose membranes filters (Millipore, Milford, MA). The filters containing the Ca2+-loaded SR vesicles were washed two times with 2 ml of a buffer containing 20 mM Mops pH 7.0, 80 mM KCl, 5 mM MgCl2 and 1 mM LaCl3. Finally, 45Ca2+ transported was measured by scintillation spectroscopy using 3 ml of scintillation cocktail per vial. The use of radioactive standards allowed us to express the Ca2+ uptake data as nmol Ca2+/mg of protein.

Membrane integrity test

In order to determine if 1,2-DCB was affecting the membrane integrity and therefore interfering with Ca2+ measurements, SR vesicles (0.01 mg/ml of protein) were loaded with 45Ca2+ by performing a Ca2+ transport assay using the active transport of SERCA as described before for Ca2+ uptake [48]. The reaction was started with 1 mM of ATP and the reaction ran for 5 s (s) until SR vesicles were loaded with detectable amounts of Ca2+. In order to determine if DCB induced vesicle leakage, the 45Ca2+-loaded vesicles were exposed to 1 mM of a 1,2-DCB right before stopping the reaction by filtration. In addition, two positive controls were incorporated in substitution for oxalate: Ca2+ ionophore (1.5 μM of A23187) in combination with 1 mM 1,2-DCB, and Ca2+ ionophore alone. Very importantly, A23187 does not allow Ca2+ to be accumulated into SR vesicles. For more details of the experiment please review Ca2+ uptake supported by oxalate above. The amount of 45Ca2+ loaded into the vesicles was determined by scintillation spectroscopy.

Ca2+ binding at equilibrium assay

The binding of Ca2+ to SERCA was tested in the absence of ATP using 45CaCl2. Unbound Ca2+ was evaluated from the filter wet volume by using [3H]glucose as a marker. This approach was used to test the Ca2+ high-affinity conformational state of SERCA (E1Ca2 stage). The effect of 1,2-DCB on E1Ca2 state was evaluated at 25 °C for 5 min in a Ca2+-saturating medium containing 20 mM Mops, pH 7.0, 5 mM MgCl2, 80 mM KCl, 0.1 mM EGTA, 0.105 mM [45Ca]CaCl2 (~5000 cpm/nmol) (10 μM free Ca2+), 1 mM [3H]glucose (~10,000 cpm/nmol), and 0.2 mg/ml of SR protein. Subsequently, we added different concentrations of 1,2-DCB. In order to test the effect of 1,2-DCB on E2 stage we used a Ca2+-free media containing 20 mM Mops, pH 7.0, 5 mM MgCl2, 80 mM KCl, 0.1 mM EGTA, 1 mM [3H]glucose (~10,000 cpm/nmol), and 0.2 mg/ml of SR protein, and different concentrations of 1,2-DCB. The incubation was performed at 25 °C for 5 min. Later, the reaction for E2 stage was supplemented by adding a buffer containing 20 mM MOPS, pH 7.0, 5 mM MgCl2, 80 mM KCl, 0.1 mM EGTA, 3.15 mM [45Ca]CaCl2 (~5000 cpm/nmol) and 1 mM [3H]glucose (~10,000 cpm/nmol) with a final free-Ca2+ concentration of 10 μM. Following, the assay was prolonged for 1 min at 25 °C. Samples of 1 ml (0.2 mg of protein) were filtered under vacuum in 0.45 μm nitrocellulose filters (Millipore, HA type). Any further washing to determine 45Ca and 3H associated with the filters and the amount of radioactivity in the filters was determined by scintillation spectroscopy. Specific binding of Ca2+ to the SERCA was calculated by subtracting unbound Ca2+ retained by the filter.

Phosphorylation of SERCA by [γ32]ATP

Maximal levels of EP (phosphorylated enzyme intermediate) were determined using [γ-32P]ATP as a substrate and starting from different incubation conditions: E1Ca2 -DCB, E2 -DCB and E2[γ-32P]ATP-DCB in similar manner as we described in previous work [25, 26]. These conditions were studied during the enzyme turnover by mixing equal volumes (0.5 ml) of SR vesicles with the phosphorylating medium with or without Ca2+ (after both solutions were mixed, the final volume was 1 ml and 0.1 mg/ml of SR protein). The SR vesicles (0.2 mg protein/ml) were suspended in a tube with 0.5 ml of 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.967 mM CaCl2 (10 μM free Ca2+), and 15 μM A23187. To measure E1Ca2-DCB stage, the reaction mixture was preincubated with a defined concentration of 1,2-DCB and the phosphorylation reaction was started by mixing 0.5 ml of this medium with 20 μl of medium containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.967 mM CaCl2, and 1.25 mM [γ-32P]ATP (50 μM final concentration, ~20,000 cpm/nmol). When the enzyme (0.2 mg/ml) was in nominally Ca2+-free medium (E2 -DCB stage), the phosphorylating medium contained CaCl2 to give 10 μM free Ca2+ after mixing. In order to determine if 1,2-DCB was directly affecting the E2ATP in a Ca2+ free medium, the formation of the EP stage was started when Ca2+ (to give 10 μM free) was added into the reaction medium. Phosphorylation time was 2 s when the enzyme turnover was studied at 0 °C, and 5 s when studied at 25 °C. The reaction was started under continuous vortexing and stopped by adding 1 ml of ice-cold 250 mM perchloric acid and 2 mM sodium phosphate. Stopped reactions were incubated on ice for 5 min before filtration through 0.45 μm nitrocellulose filters (Millipore, HA type). SR vesicles retained by the filters were washed 5 times with ice-cold 250 mM perchloric acid and 2 mM sodium phosphate. Finally, the amount of radioactivity in the filters was determined by scintillation spectroscopy. These results are expressed as nmol EP/milligram of protein.

Statistical analysis

Statistical and kinetic analysis was performed using Sigma Plot 11 software. Unless otherwise stated, the experiment values are represented as the mean of at least three independent experiments, each performed in triplicate +/− average SE, with statistical significance of p < 0.05 determined by t-student’s paired t-test.

Results

Effect of 1,2-DCB on the hydrolytic activity of SERCA supported by A23187

In order to determine the effect of 1,2-DCB on the ATP hydrolytic activity of SERCA, we titrated different 1,2-DCB concentrations in a typical Ca2+-ATPase assay where SERCA hydrolyzed ATP to ADP and Pi as described before. In this experiment we incubated SR vesicles with A23187, a Ca2+ ionophore, which is used to generate leaky vesicles (absence of gradient) in order to avoid saturation of SR vesicles with Ca2+, which would otherwise stop Ca2+-ATPase activity. The dose-response curve revealed a biphasic effect of 1,2-DCB on the ATP hydrolytic activity of SERCA: while lower concentrations of the compound highly stimulated ATP hydrolysis, 1,2-DCB concentrations higher than 0.3 mM inhibited SERCA hydrolytic activity (Fig. 1). In addition, 0.5 mM of 1,2-DCB reduced SERCA activity to 50 % (IC50 = 0.5 mM). To determine the importance of the Cl atoms on the effect of the compound on SERCA hydrolytic activity, we used the benzene molecule, which is the same ring base structure, but depleted of Cl atoms (Fig. 1, inset). A dose-response curve was performed by titrating several benzene concentrations, and we found that the benzene molecule by itself did not affect SERCA hydrolytic activity at all, indicating that Cl atoms are involved in the biphasic effect observed on SERCA hydrolytic activity.

Fig. 1
figure1

Effect of 1,2-DCB and benzene on the initial rates of ATP hydrolysis supported by A23187. The reaction was performed in a buffer containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.967 mM CaCl2, and 1.5 μM A23187. The reaction was conducted by adding 0.01 mg/ml of SR vesicles with different concentrations of 1,2-DCB (mM) or benzene (mM). First data point corresponds to Ca2+-ATPase activity without DCB (control) and it was ~2.6 ± 0.05 μmol Pi/mg∙min

Full size image

Effect of 1,2-DCB on Ca2+ uptake and ATP hydrolysis ratio mediated by SERCA and supported by K-oxalate

We next aimed to determine the effect of 1,2-DCB on Ca2+ uptake mediated by SERCA. Vesicular fragments of SR exhibit linear rates of Ca2+ transport upon addition of ATP when equilibrated in the presence of K-oxalate as a lumenal Ca2+ regulator (non leaky vesicles). In order to avoid Ca2+ leakage caused by the Ca2+ ionophore (A23187), we used K-oxalate in both Ca2+-transport and hydrolytic activity experiments in order to make them comparable to Ca2+ transport. The dose-response curves showed that 1,2-DCB did not stimulate Ca2+ uptake mediated by SERCA, but in contrast, Ca2+ uptake was inhibited by DCB concentrations above 0.5 mM until achieving full inhibition at 1 mM (Fig. 2a). Ca2+ transport cannot be measured in an assay containing a Ca2+ ionophore (as used to measure the ATP hydrolysis) therefore these experimental conditions did not allow us to compare the Ca2+ uptake assay with the previously conducted experiments of hydrolytic activity. The approach employed for Ca2+ uptake measurement is less sensitive than the one using Ca2+ ionophore and reduces enzyme activity by ~1 fold, thus showing less effect of 1,2-DCB (Fig. 2b), however, there were peaks of activation of approximately 15 and 20 % at DCB concentrations of 0.05 and 0.1 mM, respectively. Nevertheless, when we compared the ATP hydrolysis results with the ones conducted for Ca2+ uptake, we were able to find a disruption in the Ca2+ uptake/ATP hydrolysis ratio (calculated by dividing the Ca2+ transport values by those of ATP hydrolysis), which indicates that the enzyme activity ratio was uncoupled, as opposed to normal physiological conditions during which the enzyme maintains a coupled ratio of 2Ca2+ for each mol of ATP hydrolyzed to ADP and Pi (Fig. 2c). The observed ratio appears to confirm that 1,2-DCB concentrations greater than 0.05 mM cause a disturbance on the enzyme activity, an effect that is not observed only with the hydrolysis.

Fig. 2
figure2

The Ca2+-ATPase activity supported by oxalate was uncoupled by 1,2-DCB. The effect of 1,2-DCB on Ca2+/Pi coupling ratio was determined. The coupling ratio at each DCB concentration was calculated as the ratio between the Ca2+ uptake rate and the ATP hydrolysis rate by SERCA. SR vesicles (0.01 mg/ml) were equilibrated at 25 °C in a medium containing 5 mM K-oxalate. Hydrolysis rate of ATP (a) or 45Ca2+ uptake rates (b) were measured at same experimental conditions. c The Ca2+/Pi coupling ratio (calculated by dividing the Ca2+ transport values by those of ATP hydrolysis), in presence of different concentrations of 1,2-DCB was uncoupled

Full size image

Given that 1,2-DCB affected Ca2+ uptake mediated by SERCA, we aimed to determine if 1,2-DCB was also affecting the binding of Ca2+ to SERCA. Direct measurements of 45Ca2+ binding to the non-phosphorylated enzyme pre-incubated with the compound indicated that the E1 conformation remained unaffected by treatment with 1,2-DCB (Fig. 3, open circles). In contrast with the E1 form, treatment with 1,2-DCB starting from the E2 form prior to binding of Ca2+ affected only ~16 % of the total Ca2+ bound to the enzyme (Fig. 3, closed circles), but the levels remained constant with all 1,2-DCB concentrations.

Fig. 3
figure3

Binding of Ca2+ to SERCA. To test if 1,2-DCB was affecting the binding of Ca2+ to the enzyme we performed a binding assay as described in Methods . The complex Ca2+/SERCA (E1Ca2) (o) or enzyme prior binding to Ca2+ (E2) (●) were exposed to different concentrations of 1,2-DCB

Full size image

Membrane protein-dependent effect of 1,2-DCB and SR membrane integrity

1,2-DCB is a typical hydrophobic molecule and as such, it has affinity for hydrophobic environments such as biological membranes. For this reason, we used our model of study to investigate the possibility of 1,2-DCB targeting the SR membranes. First, we conducted a set of experiments using a high-dose of 1,2-DCB in reactions having 10-fold different amounts of SR vesicles (0.01–0.1 mg/ml total protein). In these experiments we tested hydrolysis of ATP mediated by SERCA and we found that the inhibitory effect of 1,2-DCB was significantly reduced with high amounts (5–10 folds higher) of SR vesicles (0.05–0.1 mg/ml total membrane protein), which strongly suggested that 1,2-DCB molecules were being diluted into the SR membranes (Fig. 4). These results indicate that DCB molecules were going from the aqueous environment of the reaction medium into the membranes, and when the number of SR vesicles was increased, there were less 1,2-DCB molecules per SR membrane. However, this does not confirm if 1,2-DCB was affecting the integrity of the SR membrane. In order to analyze if 1,2-DCB molecules were disrupting the integrity of the SR membrane, we loaded SR vesicles with Ca2+, using a typical Ca2+ uptake assay as previously described, and 5 s before stopping the reaction we added 1 mM of 1,2-DCB into the reaction mix (Fig. 5). SR vesicles treated with 1,2-DCB (open circles) did not show any difference in levels of accumulated Ca2+ inside of the SR vesicle when compared to controls (without 1,2-DCB, closed circles), thus demonstrating that 1,2-DCB did not disrupt membrane vesicles. In addition, we performed a positive control with a Ca2+ ionophore (A23187) knowing that it produces leaky vesicles and therefore does not allow Ca2+ accumulation (Fig. 5, closed and open triangles). As observed, vesicles with A23187 were only able to accumulate ~11 % of the total Ca2+ accumulated in the control at 1 min of filling (100 %). This demonstrates that, at least in short time exposure, DCB does not disrupt the SR membrane integrity, which indicates that the effect of 1,2-DCB on SERCA hydrolytic activity was due to an effect on SERCA functionality.

Fig. 4
figure4

The effect of 1,2-DCB was SR vesicles-dependent. The assay medium contained 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 1 mM EGTA, 0.967 mM CaCl2, different SR protein concentrations (0.01 and 0.10 mg/ml), and 1.5–15 μM A23187 (A23187 was proportionally increased with respect SR total protein). SERCA activity was assayed at 25 °C in absence of compound as control (white bars) and with 1 mM 1,2-DCB (gray bars). The reactions started by the addition of 1 mM ATP. Controls were normalized to 100 % of Ca2+-ATPase activity and the actual values were 2.6 ± 0.05, 2 ± 0.04, and 1.6 ± 1.3 μM Pi/min/mg. *, p = <0.001, compared to their respectively control that does not have DCB

Full size image
Fig. 5
figure5

Time-dependent filling of SR vesicles and exposure to 1,2-DCB. In order to determine the effect of 1,2-DCB on the filling of the vesicles by SERCA protein, we exposed on the SR membrane, 45Ca2+ uptake was measured under same conditions described for Ca2+ transport. At different times in Ca2+ uptake, 1,2-DCB (open circles) was added to the reaction media before stopping the reaction. The same reaction without DCB treatment was tested as a control (closed circles). Two additional positive controls were incorporated in substitution for oxalate, Ca2+ ionophore (1.5 μM of A23187) was added to the assays with (closed triangles) or without 1 mM 1,2-DCB (open triangles). Very importantly, A23187 did not allow Ca2+ to be accumulated into SR vesicles

Full size image

Formation of EP stage during the catalytic cycle of SERCA was inhibited by 1,2-DCB

The following step was to study the formation of EP stage by ATP during the turnover of SERCA, which is a crucial step in the catalytic cycle of this enzyme. Surprisingly, all the 1,2-DCB concentrations tested considerably reduced the formation of the E1P stage of SERCA (Fig. 6a). When starting from E1Ca2 plus 1,2-DCB, and the variation E2 plus 1,2-DCB started with Ca2+/ATP (inset), the EP levels were drastically reduced: E1Ca2 with 0.05 mM of 1,2-DCB barely reached 13.04 % of accumulated EP, with 0.1 and 0.2 mM of 1,2-DCB further reducing EP levels to 6.08 and 5.65 %, respectively and 0.5 mM of the compound completely abolishing EP accumulation. In the case of E2, the EP levels were similarly affected: 0.05 mM of 1,2-DCB decreased EP to 17.5 %, with 0.1 mM further reducing it to 3.0 %, and the remaining concentrations showed no EP at all (Fig. 6a, inset). The results with E2ATP plus 1,2-DCB started with Ca2+ at 0 or 25 °C were slightly different (Fig. 6b), and it appears that in this case the observed result could be more influenced by temperature. However, beside the temperature difference, a somewhat higher level of EP can still be observed at 0.05 mM of 1,2-DCB (Fig. 6b) when compared to the levels observed on Fig. 6a at the same DCB concentration, suggesting a possible protective effect by ATP, although experiments carried at zero degrees using DCB concentrations above 0.1 mM showed complete inhibition of EP formation (Fig. 6b, closed circles), but EP levels at 25 °C are greater than those observed at 0 °C. It is worth noting that the data shown in both figures does follow a similar trend, that is a consistent reduction of EP levels as the 1,2-DCB concentration increases.

Fig. 6
figure6

Effect of 1,2-DCB on functional states of SERCA as determined by ATP phosphorylation. SR vesicles at 0.1 mg of protein/ml were incubated at 25 °C in a medium containing: a 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 15 μM A23187, 0.1 mM EGTA, 10 μM free Ca2+, and a certain 1,2-DCB concentration starting with 50 μM [γ-32P]ATP (●). Inset: The E2 + 1,2-DCB prior phosphorylation was starting with 10 μM free Ca2+ and 50 μM [γ-32P]ATP (○). The phosphorylation in each case was maintained for 2 s at 0 °C. b For phosphorylation initiating from E2ATP Ca2+ free, the enzyme (0.1 mg of protein/ml) was first treated with 1,2-DCB in a media containing 20 mM Mops, pH 7.0, 80 mM KCl, 5 mM MgCl2, 15 μM A23187, 0.1 mM EGTA, followed by phosphorylation at 0 °C or 25 °C by adding [γ-32P]ATP and 10 μM free Ca2+. For more details see Methods

Full size image

Discussion

Our data show that 1,2-DCB exerts a dual response of stimulation and inhibition in SERCA hydrolytic activity supported by A23187 (Fig. 1). Similar effects of activation and inhibition of SERCA caused by other hydrophobic compounds have been reported in the literature, and possible explanations include alterations in the lipid environment of the enzyme, as well as accessing sensitive domains of the pump due to their hydrophobic properties [49–51]. The 1,2-DCB molecule possesses two Cl atoms in the benzene ring. In order to test the importance of the Cl atoms on the effect of this molecule on SERCA, we used benzene (which lacks Cl atoms) and we were able to avoid the inhibitory and stimulatory effects on SERCA activity produced by 1,2-DCB (Fig. 1). Our data supports a clear relation between the structure of 1,2-DCB and the effect produced on the ATP hydrolytic activity, since the absence of Cl atoms does not cause any effect on SERCA. Similar conclusions have been previously reported regarding the effects caused by the presence of electronegative groups [52–54]. Moreover, hydrophobic molecules can interact with hydrophobic domains in the membrane proteins, thus affecting enzyme functionality [37, 53, 55].

We also addressed the possibility of 1,2-DCB affecting the activity of binding/translocation of Ca2+ by SERCA. Surprisingly, a 1 mM concentration of 1,2-DCB fully inhibited Ca2+ uptake without affecting Ca2+-binding, which suggests that the binding of Ca2+ is not a major problem for the inhibition of Ca2+ transport. However, this is indicative that 1,2-DCB is affecting the Ca2+ sensitive conformation of the enzyme to a lesser extent (Figs. 2a and 3 respectively). Nevertheless, our data of binding of Ca2+ suggested that Ca2+ was able to bind to the enzyme in turnover conditions almost at normal levels, even when Ca2+ uptake was completely inhibited at the highest DCB concentration. Therefore, it was necessary to study the hydrolytic activity of SERCA under the same conditions used for the Ca2+ transport assay, using K-oxalate instead of the Ca2+ ionophore. When intravesicular Ca2+ levels get higher (~2–3 mM), Ca2+ reacts with oxalate to form calcium oxalate thus precipitating inside of the intact vesicle as crystals [13], which allows us to measure the enzyme activity in min. Surprisingly, we found that the hydrolytic activity of SERCA under these same conditions was still stimulated, but not inhibited at the same concentrations tested before (Fig. 3b). This may be due to the different experimental conditions such as the presence of ionophore, which allows the system to function more efficiently. The Ca2+-ionophore acts as a freely mobile carrier that transports Ca2+ across the membrane, and it is possible that it is acting simultaneously with the 1,2-DCB, stimulating the pump due to increased membrane permeability and absence of gradient [13, 56, 57]. This could explain why activation and inhibition are more pronounced when measured with the Ca2+-ionophore than when measured with K-oxalate, where the vesicle interior is not gradient-free. We also found that the Ca2+/Pi ratio was partially uncoupled at 1,2-DCB concentrations between 0.05 and 0.5 mM, and fully uncoupled at 1 mM. This phenomenon of uncoupled Ca2+-ATPase with a lower Ca2+/Pi ratio has been previously described in terms of the increased thermogenic activity that occurs when using intact vesicles [13–15], where it was found that after Ca2+ saturation, ~82 % of the hydrolytic activity is uncoupled from the Ca2+ transport, thus decreasing the Ca2+/Pi ratio.

Previous reports showed that non-polar organic solvents facilitate the incorporation of hydrophobic compounds to cell membranes, and that enzymatic stimulation or inhibition is related to both solvent and membrane protein quantity [38, 49]. In agreement with the literature, 1,2-DCB affects SERCA activity by sharing these features, as we further demonstrated that the inhibitory effect of 1,2-DCB was SR membrane-dependent (Fig. 4). This could be due to a partitioning effect of the DCB into the membrane fraction, which indicates that activation or inhibition is dependent on membrane composition and protein concentration. Organic solvents can reduce the inhibition of SERCA by certain drugs, which explains how hydrophobic drugs can move to a lipid environment in the membrane, thus causing enzyme inhibition [49, 50, 58]. Data from Lax et al. [59] showed that the addition of phosphatidylcholine liposomes to SERCA reactions caused a decrease in the inhibitory effect of the fungicide miconazol. 1,2-DCB shares similar features to those of miconazole and therefore, we believe that our data indicates that DCB is going into the SR vesicles because of its hydrophobic properties.

The Ca2+ uptake assay employed in this study measured accumulated Ca2+ inside the SR vesicles [48, 60]. However, if 1,2-DCB disrupts the time required to fill the vesicles with Ca2+, this may be reflected as an inhibition on the accumulated Ca2+ due to a loss of Ca2+ caused by vesicle damage. Molecules such as 1,2-DCB can target SR membranes affecting the filling time of SR vesicles by the SERCA pump. For example, hexachlorocyclohexane, a hydrophobic compound, was shown to affect the activity of membrane proteins by disrupting the lipid bilayer [55]. For this reason, we filled out SR vesicles with Ca2+ using the active transport of SERCA, followed by the addition of a high concentration of DCB (1 mM) 5 s before stopping the reaction. In agreement with our previous findings, 1,2-DCB was unable to decrease the levels of accumulated Ca2+ when compared to controls (without DCB) (Fig. 5). Given that vesicle filling occurs in less than 1 s, which is the physiological time during which muscle relaxation occurs [15], we selected a longer vesicle filling time. This data clearly demonstrates that 1,2-DCB is not affecting the vesicle filling time by causing disturbances of the SR membrane. This was supported by our a positive control using Ca2+ ionophore A23187 (absence of gradient) alone or with 1 mM 1,2-DCB, which did not allow accumulation of Ca2+ inside the SR vesicles (Fig. 5). This phenomenon is referred to in the literature as “leaky vesicles”, since this system allows the efflux of luminal Ca2+, thus obtaining faster efflux [61, 62]. It was interesting to find that the SR membrane was not disrupted, which supports our findings that 1,2-DCB is causing uncoupling of the Ca2+/Pi ratio. Considering this phenomenon applied to a biological system, we can refer to the thermogenic activity previously proposed by Inesi and Tadini-Buoninsegni [15], where SERCA1 uncoupling interferes with the decrease of cytosolic Ca2+ and the subsequent relaxation of muscle fibers. If we take into account that vesicles are filled with Ca2+ in less than 1 s, a sufficient concentration of luminal Ca2+ would not be reached, thus preventing the dissociation of the E2-P.Ca2 form. This phenomenon could not lead to thermogenic activity due to a basal state of the pump. The Ca2+ leakage from the pump could occur if the luminal Ca2+ concentration reached such high levels that both its E2-P.Ca2 dissociation constant and the cytosolic Ca2+ concentrations would remain above the required levels to achieve maximal pump activation, which could occur under prolonged muscle activity. Even though the cytosolic Ca2+ levels can remain high due to multiple action potentials, this does not appear to be our case, since we have no evidence of pump overload (Figs. 2a and 5).

In order to get more insights into the mechanism by which 1,2-DCB caused uncoupling of the SERCA activity, we studied the E1P step of the enzyme. Our results demonstrated that 1,2-DCB decreased the EP stage formation but was influenced by temperature when starting from E2ATP, even when our previous experiments showed that 1,2-DCB produced a high rate of ATP hydrolysis. Our initial expectation was to observe elevated levels of EP by ATP, since it is common that hydrophobic molecules affect the E2 state of SERCA which prevents or decreases the transition to the E1 stage [25, 63]. Our data of EP inhibition suggests that 1,2-DCB (Fig. 6) could be affecting the E2 step. Similar examples of this phenomenon are found in the literature [15, 49, 51, 64, 65]. Taken together, the inhibition of the EP stage and our previous results could explain why an uncoupled Ca2+/Pi ratio was observed, even when Ca2+ is binding to the enzyme in the presence of 1,2-DCB. Phosphorylation of the enzyme is necessary for the appropriate Ca2+ transport across the SR membrane. Therefore, it is possible that a Ca2+ slippage process is taking place, where ATP hydrolysis is occurring without the subsequent accumulation of the transient E1P form and without Ca2+ transport, with Ca2+ “slipping” into the outside of the vesicles. This can be affected by several factors such as time, temperature, enzymatic stage and in our case the DCB concentration [66, 67] Our data shows that at 25 °C, EP levels were increased (Fig. 6b). However, the measurements followed the same pattern of EP decrease with increasing DCB concentration. Regarding the EP measurements conducted at 0 °C, which seem to go against the literature, it is well established that high levels of EP are obtained at low temperatures (0 °C) due to the rapid transition of the limiting E1P.Ca2 step to E2P.Ca2, and the subsequent Ca2+ translocation that leads to the EP decomposition [68], in other words, the phosphoenzyme formed from ATP is more sensitive to ADP at 0 °C than at 30 °C, thus confirming that ATP hydrolysis coupled to Ca2+ efflux and the ATP↔Pi exchange reaction are inhibited at 0 °C [69]. However, the experiments starting from E2ATP showed higher levels of accumulated EP, but these experiments were conducted at 0 and 25 °C, where A23187 is also present (although protein concentration, time and ATP are different). At 0.05 mM DCB, ~30–40 % of accumulated EP can be observed at both temperatures, indicating that ATP could be protecting the enzyme from inhibition. However, higher DCB concentrations (0.1 mM and subsequent) caused a drastic decrease in EP levels (Fig. 6b, filled circles). Other factors that could affect the E1P to E2P transition include detergents and the microviscosity of the lipid environment of the ATPase [70]. Temperature is another important factor that could potentially affect this transition, as it has been demonstrated that at 21 °C the E1P to E2P isomerization is rapidly affected at high KCl concentrations [71]. Temperature is also important for compound solubility in aqueous solutions, as it has been shown that the solubility of aroma compounds (such as methyl ketones, ethyl esters, aldehyde and alcohol) decreases when incubated on ice as the concentration of the compound is increased, which could contribute to explain the effect of temperature and DCB solubility at 0 and 25 °C in the EP measurements [72].

Conclusions

Our data demonstrates that 1,2-DCB affects the ATP hydrolytic activity of SERCA, causing both stimulation and inhibition of ATP hydrolysis. This dual effect caused by 1,2-DCB fits it into a common pattern displayed by several other hydrophobic compounds. We also found that 1,2-DCB partially inhibited Ca2+ transport and EP stage formation due to uncoupled enzyme activity, even without affecting the Ca2+ bound to the enzyme. Finally, to the best of our knowledge, this is the first study designed to study the effect of 1,2-DCB, a chemical that is widely found in the environment, on the functionality of SERCA proteins, and thus the data presented here not only provide insights into the molecular mechanisms of the enzyme’s catalytic cycle, but on the possible toxic effects caused by 1,2-DCB.

References

  1. 1.

    Yoshida T, Andoh K, Kosaka H, Kumagai S, Matsunaga I, Akasaka S, et al. Inhalation toxicokinetics of p-dichlorobenzene and daily absorption and internal accumulation in chronic low-level exposure to humans. Arch Toxicol. 2002;76:306–15.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Bristol DW, Crist HL, Lewis RG, MacLeod KE, Sovocool GW. Chemical analysis of human blood for assessment of environmental exposure to semivolatile organochlorine chemical contaminants. J Anal Toxicol. 1982;6:269–75.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Kumagai S, Matsunaga I. Identification of urinary metabolites of human subjects exposed to o-dichlorobenzene. Int Arch Occup Environ Health. 1995;67:207–9.

    CAS  PubMed  Google Scholar 

  4. 4.

    Jan J. Chlorobenzene residues in human fat and milk. Bull Environ Contam Toxicol. 1983;30:595–9.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Mes J, Davies DJ, Turton D, Sun WF. Levels and trends of chlorinated hydrocarbon contaminants in the breast milk of Canadian women. Food Addit Contam. 1986;3:313–22.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Hsiao PK, Lin YC, Shih TS, Chiung YM. Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions. Int Arch Occup Environ Health. 2009;82:1077–85.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Hissink AM, Van Ommen B, Van Bladeren PJ. Dose-dependent kinetics and metabolism of 1,2-dichlorobenzene in rat: effect of pretreatment with phenobarbital. Xenobiotica. 1996;26:89–105.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Yan RM, Chiung YM, Pan CY, Liu JH, Liu PS. Effects of dichlorobenzene on acetylcholine receptors in human neuroblastoma SH-SY5Y cells. Toxicology. 2008;253:28–35.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    MacLennan DH, Green NM. Structural biology. Pumping ions. Nat. 2000;405:633–4.

    CAS  Article  Google Scholar 

  10. 10.

    Toyofuku T, Kurzydlowski K, Tada M, MacLennan DH. Identification of regions in the Ca(2+)-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J Biol Chem. 1993;268:2809–15.

    CAS  PubMed  Google Scholar 

  11. 11.

    MacLennan DH, Klip A. Calcium transport and release by sarcoplasmic reticulum: a mini-review. Soc Gen Physiol Ser. 1979;33:61–75.

    CAS  PubMed  Google Scholar 

  12. 12.

    MacLennan DH. Purification and properties of an adenosine triphosphatase from sarcoplasmic reticulum. J Biol Chem. 1970;245:4508–18.

    CAS  PubMed  Google Scholar 

  13. 13.

    Barata H, de Meis L. Uncoupled ATP hydrolysis and thermogenic activity of the sarcoplasmic reticulum Ca2 + −ATPase: coupling effects of dimethyl sulfoxide and low temperature. J Biol Chem. 2002;277:16868–72.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Martonosi A, Feretos R. Sarcoplasmic reticulum. II. Correlation between adenosine triphosphatase activity and Ca++ uptake. J Biol Chem. 1964;239:659–68.

    CAS  PubMed  Google Scholar 

  15. 15.

    Inesi G, Tadini-Buoninsegni F. Ca/H exchange, lumenal Ca release and Ca/ATP coupling ratios in the sarcoplasmic reticulum ATPase. J Cell Commun Signal. 2014;8:5–11.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    de Meis L, Vianna AL. Energy interconversion by the Ca2 + −dependent ATPase of the sarcoplasmic reticulum. Annu Rev Biochem. 1979;48:275–92.

    Article  PubMed  Google Scholar 

  17. 17.

    de Meis L. Approaches to studying the mechanisms of ATP synthesis in sarcoplasmic reticulum. Methods Enzymol. 1988;157:190–206.

    Article  PubMed  Google Scholar 

  18. 18.

    Henao F, Delavoie F, Lacapere JJ, McIntosh DB, Champeil P. Phosphorylated Ca2 + −ATPase stable enough for structural studies. J Biol Chem. 2001;276:24284–5.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Toyoshima C, Nakasako M, Nomura H, Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature. 2000;405:647–55.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Sorensen TL, Clausen JD, Jensen AM, Vilsen B, Moller JV, Andersen JP, et al. Localization of a K + − binding site involved in dephosphorylation of the sarcoplasmic reticulum Ca2 + − ATPase. J Biol Chem. 2004;279:46355–8.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Sorensen TL, Moller JV, Nissen P. Phosphoryl transfer and calcium ion occlusion in the calcium pump. Science. 2004;304:1672–5.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Toyoshima C, Iwasawa S, Ogawa H, Hirata A, Tsueda J, Inesi G. Crystal structures of the calcium pump and sarcolipin in the Mg2 + −bound E1 state. Nature. 2013;495:260–4.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Inesi G. Mechanism of calcium transport. Annu Rev Physiol. 1985;47:573–601.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Michelangeli F, East JM. A diversity of SERCA Ca2+ inhibitors. Biochem Soc Trans. 2011;39:789–97.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Plenge-Tellechea F, Soler F, Fernandez-Belda F. On the inhibition mechanism of sarcoplasmic or endoplasmic reticulum Ca2 + −ATPases by cyclopiazonic acid. J Biol Chem. 1997;272:2794–800.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Soler F, Plenge-Tellechea F, Fortea I, Fernandez-Belda F. Cyclopiazonic acid effect on Ca2 + −dependent conformational states of the sarcoplasmic reticulum ATPase. Implication for the enzyme turnover. Biochemistry. 1998;37:4266–74.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Thastrup O, Cullen PJ, Drøbak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci. 1990;87:2466–70.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Aureliano M, Tiago T, Gândara RM, Sousa A, Moderno A, Kaliva M, Salifoglou A, Duarte RO, Moura JJ. Interactions of vanadium(V)-citrate complexes with the sarcoplasmic reticulum calcium pump. J Inorg Biochem. 2005;99:2355–61.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Aureliano M, Henao F, Tiago T, Duarte RO, Moura JJ, Baruah B, Crans DC. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue. Inorg Chem. 2008;47:5677–84.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Fraqueza G, Ohlin CA, Casey WH, Aureliano M. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate. J Inorg Biochem. 2012;107:82–9.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Aureliano M, Fraqueza G, Ohlin CA. Ion pumps as biological targets for decavanadate. Dalton Trans. 2013;42:11770–7.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Antipenko AY, Spielman AI, Kirchberger MA. Interactions of 6-gingerol and ellagic acid with the cardiac sarcoplasmic reticulum Ca2 + −ATPase. J Pharmacol Exp Ther. 1999;290:227–34.

    CAS  PubMed  Google Scholar 

  33. 33.

    Namekata I, Hamaguchi S, Wakasugi Y, Ohhara M, Hirota Y, Tanaka H. Ellagic acid and gingerol, activators of the sarco-endoplasmic reticulum Ca2+-ATPase, ameliorate diabetes mellitus-induced diastolic dysfunction in isolated murine ventricular myocardia. Eur J Pharmacol. 2013;706:48–55.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Christensen SB, Skytte DM, Denmeade SR, Dionne C, Møller JV, Nissen P, Isaacs JT. A Trojan horse in drug development: targeting of thapsigargins towards prostate cancer cells. Anticancer Agents Med Chem. 2009;9:276–94.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Ogunbayo OA, Harris RM, Waring RH, Kirk CJ, Michelangeli F. Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2 + −ATPase by flavonoids: a quantitative structure-activity relationship study. IUBMB Life. 2008;60:853–8.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Salama G, Scarpa A. Enhanced Ca2+ uptake and ATPase activity of sarcoplasmic reticulum in the presence of diethyl ether. J Biol Chem. 1980;255:6525–8.

    CAS  PubMed  Google Scholar 

  37. 37.

    Almeida LM, Vaz WL, Stumpel J, Madeira VM. Effect of short-chain primary alcohols on fluidity and activity of sarcoplasmic reticulum membranes. Biochemistry. 1986;25:4832–9.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Bigelow DJ, Thomas DD. Rotational dynamics of lipid and the Ca-ATPase in sarcoplasmic reticulum. The molecular basis of activation by diethyl ether. J Biol Chem. 1987;262:13449–56.

    CAS  PubMed  Google Scholar 

  39. 39.

    Michelangeli F, Orlowski S, Champeil P, East JM, Lee AG. Mechanism of inhibition of the (Ca2(+)-Mg2+)-ATPase by nonylphenol. Biochemistry. 1990;29:3091–101.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Ishida Y, Honda H. Inhibitory action of 4-aminopyridine on Ca(2+)-ATPase of the mammalian sarcoplasmic reticulum. J Biol Chem. 1993;268:4021–4.

    CAS  PubMed  Google Scholar 

  41. 41.

    Carfagna MA, Muhoberac BB. Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity. Mol Pharmacol. 1993;44:129–41.

    CAS  PubMed  Google Scholar 

  42. 42.

    Eletr S, Inesi G. Phospholipid orientation in sarcoplasmic membranes: spin-label ESR and proton MNR studies. Biochim Biophys Acta. 1972;282:174–9.

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–75.

    CAS  PubMed  Google Scholar 

  44. 44.

    Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378–417.

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    Schwarzenbach G, Senn H, Komplexone AG, XXIX. Ein grosser Chelateffekt besonderer Art. Helv Chim Acta. 1957;40:1886–900.

    CAS  Article  Google Scholar 

  46. 46.

    Blinks JR, Wier WG, Hess P, Prendergast FG. Measurement of Ca2+ concentrations in living cells. Prog Biophys Mol Biol. 1982;40:1–114.

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Lin TI, Morales MF. Application of a one-step procedure for measuring inorganic phosphate in the presence of proteins: the actomyosin ATPase system. Anal Biochem. 1977;77:10–7.

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Martonosi A, Feretos R. Sarcoplasmic reticulum. I. The uptake of Ca++ by sarcoplasmic reticulum fragments. J Biol Chem. 1964;239:648–58.

    CAS  PubMed  Google Scholar 

  49. 49.

    Petretski JH, Wolosker H, de Meis L. Activation of Ca2+ uptake and inhibition of reversal of the sarcoplasmic reticulum Ca2+ pump by aromatic compounds. J Biol Chem. 1989;264:20339–43.

    CAS  PubMed  Google Scholar 

  50. 50.

    Wakabayashi S, Ogurusu T, Shigekawa M. Mechanism for 3,3′,4′,5-tetrachlorosalicylanilide-induced activation of sarcoplasmic reticulum ATPase. J Biol Chem. 1988;263:15304–12.

    CAS  PubMed  Google Scholar 

  51. 51.

    Martinez-Azorin F, Teruel JA, Fernandez-Belda F, Gomez-Fernandez JC. Effect of diethylstilbestrol and related compounds on the Ca(2+)-transporting ATPase of sarcoplasmic reticulum. J Biol Chem. 1992;267:11923–9.

    CAS  PubMed  Google Scholar 

  52. 52.

    Khan YM, Wictome M, East JM, Lee AG. Interactions of dihydroxybenzenes with the Ca(2+)-ATPase: separate binding sites for dihydroxybenzenes and sesquiterpene lactones. Biochemistry. 1995;34:14385–93.

    CAS  Article  PubMed  Google Scholar 

  53. 53.

    Soler F, Plenge-Tellechea F, Fortea I, Fernandez-Belda F. Clomipramine and related structures as inhibitors of the skeletal sarcoplasmic reticulum Ca2+ pump. J Bioenerg Biomembr. 2000;32:133–42.

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Logan-Smith MJ, Lockyer PJ, East JM, Lee AG. Curcumin, a molecule that inhibits the Ca2 + −ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+. J Biol Chem. 2001;276:46905–11.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Bhalla P, Agrawal D. Alterations in rat erythrocyte membrane due to hexachlorocyclohexane (technical) exposure. Hum Exp Toxicol. 1998;17:638–42.

    CAS  Article  PubMed  Google Scholar 

  56. 56.

    Hara H, Kanazawa T. Selective inhibition by ionophore A23187 of the enzyme isomerization in the catalytic cycle of sarcoplasmic reticulum Ca2 + −ATPase. J Biol Chem. 1986;261:16584–90.

    CAS  PubMed  Google Scholar 

  57. 57.

    Peter HW, Wolf HU. Kinetics of (Na +, K +)-ATPase of human erythrocyte membranes. I. Activation by Na + and K +. Biochim Biophys Acta. 1972;290:300–9.

    CAS  Article  PubMed  Google Scholar 

  58. 58.

    De Meis L, Tuena de Gomez Puyou M, Gomez Puyou A. Inhibition of mitochondrial F1 ATPase and sarcoplasmic reticulum ATPase by hydrophobic molecules. Eur J Biochem. 1988;171:343–9.

    Article  PubMed  Google Scholar 

  59. 59.

    Lax A, Soler F, Fernandez-Belda F. Inhibition of sarcoplasmic reticulum Ca2 + −ATPase by miconazole. Am J Physiol Cell Physiol. 2002;283:C85–92.

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    de Meis L, Hasselbach W, Machado RD. Characterization of calcium oxalate and calcium phosphate deposits in sarcoplasmic reticulum vesicles. J Cell Biol. 1974;62:505–9.

    Article  PubMed  PubMed Central  Google Scholar 

  61. 61.

    Ohmiya H, Kanazawa T. Inhibition by A23187 of conformational changes involved in the Ca(2+)-induced activation of sarcoplasmic reticulum Ca(2+)-ATPase. J Biochem. 1991;109:751–7.

    CAS  PubMed  Google Scholar 

  62. 62.

    Hara H, Ohmiya H, Kanazawa T. Selective inhibition by ionophore A23187 of the enzyme isomerization in the catalytic cycle of Na+, K + − ATPase. J Biol Chem. 1988;263:3183–7.

    CAS  PubMed  Google Scholar 

  63. 63.

    Wictome M, Michelangeli F, Lee AG, East JM. The inhibitors thapsigargin and 2,5-di(tert-butyl)-1,4-benzohydroquinone favour the E2 form of the Ca2+, Mg2 + −ATPase. FEBS Lett. 1992;304:109–13.

    CAS  Article  PubMed  Google Scholar 

  64. 64.

    Hua S, Xu C, Ma H, Inesi G. Interference with phosphoenzyme isomerization and inhibition of the sarco-endoplasmic reticulum Ca2+ ATPase by 1,3-dibromo-2,4,6-tris(methylisothiouronium) benzene. J Biol Chem. 2005;280:17579–83.

    CAS  Article  PubMed  Google Scholar 

  65. 65.

    Berman M, Karlish S. Interaction of an aromatic dibromoisothiouronium derivate with the Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum. Biochemistry. 2003;42:3356–66.

    Article  Google Scholar 

  66. 66.

    Smith WS, Broadbridge R, East JM, Lee AG. Sarcolipin uncouples hydrolysis of ATP from accumulation of Ca2+ by the Ca2 + −ATPase of skeletal-muscle sarcoplasmic reticulum. Biochem J. 2002;361:277–86.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Reis M, Farage M, de Souza AC, de Meis L. Correlation between uncoupled ATP hydrolysis and heat production by the sarcoplasmic reticulum Ca2 + −ATPase: coupling effect of fluoride. J Biol Chem. 2001;276:42793–800.

    CAS  Article  PubMed  Google Scholar 

  68. 68.

    Wakabayashi S, Ogurusu T, Shigekawa M. Factors influencing calcium release from the ADP-sensitive phosphoenxyme intermediate of the sarcoplasmic reticulum ATPase. J Biol Chem. 1986;264:9762–9.

    Google Scholar 

  69. 69.

    Masuda H, de Meis L. Effect of temperature on the Ca2+ transport ATPase of sarcoplasmic reticulum. J Biol Chem. 1977;252:8567–71.

    CAS  PubMed  Google Scholar 

  70. 70.

    Andersen JP, Jørgensen PL, Møller JV. Direct demonstration of structural changes in soluble, monomeric Ca2 + −ATPase associated with Ca2+ release during the transport cycle. Proc Natl Acad Sci. 1985;82:4573–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  71. 71.

    Froehlich JP, Heller PF. Transient-state kinetics of the ADP-insensitive phosphoenzyme in sarcoplasmic reticulum: implications for transient-state calcium translocation. Biochemistry. 1985;24:126–36.

    CAS  Article  PubMed  Google Scholar 

  72. 72.

    Covarrubias-Cervantes M, Champion D, Debeaufort F, Voilley A. Translational diffusion coefficients of volatile compounds in various aqueous solutions at low and subzero temperatures. J Agric Food Chem. 2005;53:6671–6.

    Article  Google Scholar 

Download references

Acknowledgements

This project was supported by grant PIFI for CA-02 Diagnosis Academic Group from the Universidad Autónoma de Ciudad Juárez (UACJ), Chihuahua, México. Our recognition of the support provided by Dr. Eppie Rael through NIH grants S06 GM08012 and G12 RR08124 from the University of Texas at El Paso, TX, USA. We also wish to acknowledge the recommendations and comments made by Dr. Armando Gómez-Puyou and Dr. Marietta Tuena de Gómez from the Instituto de Fisiología Celular, UNAM, México.

Author information

Affiliations

  1. Departamento de Ciencias Químico Biológicas, Laboratorio de Biología Molecular y Bioquímica (Edif. T-216), Instituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Plutarco Elías Calles #1210 Fovissste Chamizal, Ciudad Juárez, Chihuahua, C.P. 32310, Mexico

    Luis F. Plenge-Tellechea

  2. Present address: Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, 79968, USA

    Jorge A. Sierra-Fonseca

  3. Present address: Department of Biomedical Sciences, Center of Emphasis for Neurosciences, Texas Tech University Health Science Center, El Paso, TX, 79905, USA

    Javier Vargas-Medrano

Authors
  1. Javier Vargas-Medrano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge A. Sierra-Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis F. Plenge-Tellechea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis F. Plenge-Tellechea.

Additional information

Competing interests

The authors of this manuscript declare that they have no competing interests.

Authors’ contributions

JVM carried out the majority of the ATPase activity experiments, including preparation of SR vesicles, Ca2+ transport experiments, also participating in data analysis and drafting the manuscript. JASF prepared SR vesicles used in different assays, conducted ATP hydrolysis measurements and participated in data analysis and manuscript preparation. LFPT conceived the study, prepared SR vesicles, measurement of Ca2+ transport and phosphorylation assays experiments, analyzed and interpreted experimental data, participated in manuscript drafting and directed the study. All authors approved the final version of this manuscript.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vargas-Medrano, J., Sierra-Fonseca, J.A. & Plenge-Tellechea, L.F. 1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca2+-ATPase from sarcoplasmic reticulum. BMC Biochem 17, 5 (2016). https://doi.org/10.1186/s12858-016-0061-1

Download citation

Keywords

  • Ca2+-ATPase
  • Sarcoplasmic reticulum
  • Dichlorobenzene
  • Phosphoenzyme

BMC Biochemistry

ISSN: 1471-2091

Contact us